GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Holdings Trimmed by 9258 Wealth Management LLC

9258 Wealth Management LLC lessened its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 22.2% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,546 shares of the company’s stock after selling 727 shares during the period. 9258 Wealth Management LLC’s holdings in GE HealthCare Technologies were worth $231,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in GE HealthCare Technologies by 14.7% in the third quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company’s stock worth $3,029,917,000 after acquiring an additional 5,693,244 shares during the last quarter. Norges Bank acquired a new position in GE HealthCare Technologies during the 4th quarter valued at approximately $229,052,000. Capital Research Global Investors grew its stake in GE HealthCare Technologies by 2.8% during the 4th quarter. Capital Research Global Investors now owns 51,344,719 shares of the company’s stock worth $3,969,975,000 after buying an additional 1,401,566 shares during the last quarter. Perpetual Ltd acquired a new stake in GE HealthCare Technologies in the first quarter worth $96,135,000. Finally, Stonegate Investment Group LLC lifted its stake in GE HealthCare Technologies by 3,555.0% in the fourth quarter. Stonegate Investment Group LLC now owns 654,391 shares of the company’s stock valued at $50,598,000 after buying an additional 636,487 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on GEHC shares. Evercore ISI increased their price objective on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. Citigroup increased their price objective on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Bank of America dropped their target price on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 1st. Argus upped their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, April 1st. Finally, The Goldman Sachs Group began coverage on shares of GE HealthCare Technologies in a research report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price for the company. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $94.09.

GE HealthCare Technologies Stock Up 1.0 %

Shares of NASDAQ:GEHC traded up $0.81 on Thursday, reaching $79.95. The company had a trading volume of 1,744,628 shares, compared to its average volume of 3,126,177. The stock has a market capitalization of $36.49 billion, a P/E ratio of 23.60, a P/E/G ratio of 2.75 and a beta of 1.20. The stock has a 50-day moving average price of $78.72 and a 200 day moving average price of $81.87. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.11.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, hitting the consensus estimate of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The firm had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.80 billion. During the same period in the previous year, the company earned $0.85 EPS. The company’s revenue for the quarter was down 1.2% on a year-over-year basis. On average, equities analysts expect that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a $0.03 dividend. The ex-dividend date is Friday, July 19th. This represents a $0.12 dividend on an annualized basis and a yield of 0.15%. GE HealthCare Technologies’s payout ratio is presently 3.51%.

Insiders Place Their Bets

In other news, CEO Jan Makela sold 20,227 shares of the firm’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $81.57, for a total value of $1,649,916.39. Following the sale, the chief executive officer now directly owns 63,348 shares of the company’s stock, valued at $5,167,296.36. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, CEO Jan Makela sold 20,227 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $81.57, for a total transaction of $1,649,916.39. Following the completion of the transaction, the chief executive officer now directly owns 63,348 shares in the company, valued at $5,167,296.36. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Frank R. Jimenez acquired 1,315 shares of the stock in a transaction dated Wednesday, May 1st. The stock was bought at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the purchase, the insider now owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The disclosure for this purchase can be found here. Insiders sold a total of 90,482 shares of company stock valued at $7,369,137 in the last quarter. Insiders own 0.27% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.